Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat

Citation
K. Fecho et Dt. Lysle, Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat, CELL IMMUN, 195(2), 1999, pp. 137-146
Citations number
50
Categorie Soggetti
Immunology
Journal title
CELLULAR IMMUNOLOGY
ISSN journal
00088749 → ACNP
Volume
195
Issue
2
Year of publication
1999
Pages
137 - 146
Database
ISI
SICI code
0008-8749(19990801)195:2<137:PAOSSF>2.0.ZU;2-O
Abstract
Prior studies by our laboratory demonstrated that a single injection of mor phine produces dose-dependent, naltrexone-reversible, suppressive effects i n assays of mitogen-stimulated lymphocyte proliferation and natural killer (NK) cell cytotoxicity in the spleen. The present study used how cytometry to assess directly whether acute morphine treatment produces these immune a lterations by altering the leukocyte composition of the spleen. In agreemen t with our previous findings, morphine suppressed the concanavalin A-stimul ated proliferation of T cells, lipopolysaccharide-stimulated proliferation of B cells, and NK cell cytotoxicity in the spleen. However, the same morph ine treatment protocol did not alter the total number of splenic leukocytes , the percentage of live splenic leukocytes (as assessed by forward-scatter versus side-scatter histograms), or the relative number of CD4(+)CD3(+) T cells, CD8(+)CD3(+) T cells, CD45RA/B+ B cells, NKR-P1A(hi)CD3(-) NK cells, NKR-P1A(lo)CD3(+) T cells, CD11b/c(+)HIS48(-) monocytes/macrophages, or CD 11b/c(+)HIS48(+) granulocytes in the spleen. These findings indicate that t he effects of a single sc dose of morphine on functional measures of immune status in the spleen do not result from a redistribution of splenic leukoc ytes; instead, morphine's effects likely result from direct alterations in leukocyte activities. (C) 1999 Academic Press.